/newsroom/ en /newsroom/news/list/2025/04/24/platform-technology-unlocks-new-therapeutic-targets Researchers from the University of 新浪彩票 have developed a new technology for drug and functional genomics screenings, which could reshape the way diseases are treated.聽 April 29 2025 Rhiannon Koch /newsroom/news/list/2025/04/24/platform-technology-unlocks-new-therapeutic-targets /newsroom/news/list/2025/04/07/stem-cell-funding-to-benefit-epigenetic-study A team of researchers from the University of 新浪彩票 have received funding to help improve the lives of patients with rare neurodevelopmental disorders. April 07 2025 Rhiannon Koch /newsroom/news/list/2025/04/07/stem-cell-funding-to-benefit-epigenetic-study /newsroom/news/list/2024/12/18/saigenci-researchers-given-a-funding-boost Researchers from the South Australian immunoGENomics Cancer Institute (SAiGENCI), based at the University of 新浪彩票, have been awarded funding to further their work in prostate and pancreatic cancers. December 18 2024 Rhiannon Koch /newsroom/news/list/2024/12/18/saigenci-researchers-given-a-funding-boost /newsroom/news/list/2024/10/28/fellowship-for-fundamental-epigenetic-research A University of 新浪彩票 researcher investigating the essential processes of cells with the aim of opening up new opportunities for cancer treatment has received a national award. October 29 2024 Rhiannon Koch /newsroom/news/list/2024/10/28/fellowship-for-fundamental-epigenetic-research /newsroom/news/list/2024/10/23/epigenetic-leader-becomes-universitys-first-viertel-fellow University of 新浪彩票 molecular epigenetic expert Dr Luke Isbel has been awarded a 2024 Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship. October 23 2024 Rhiannon Koch /newsroom/news/list/2024/10/23/epigenetic-leader-becomes-universitys-first-viertel-fellow /newsroom/news/list/2024/05/21/im-still-alive-because-of-it-cancer-survivors-research-request An 新浪彩票 mother who was diagnosed with breast cancer at the age of 37 has urged people to dig deep to support cancer research, saying she wouldn鈥檛 be here today if not for science and her young daughter. May 21 2024 Jessica Stanley /newsroom/news/list/2024/05/21/im-still-alive-because-of-it-cancer-survivors-research-request /newsroom/news/list/2023/09/27/cancer-researchers-leading-new-role-at-saigenci A world-leading researcher is bringing their cutting-edge cancer expertise and search for better treatments to South Australia. September 27 2023 Jessica Stanley /newsroom/news/list/2023/09/27/cancer-researchers-leading-new-role-at-saigenci /newsroom/news/list/2023/05/11/saigenci-recruit-recognised-with-prestigious-award Internationally recognised cancer expert, Professor Brendan Jenkins, has received the International Cytokine and Interferon Society (ICIS) 2023 Distinguished Service Award. He will be presented with the award at the annual ICIS conference in Athens, Greece, in October this year. May 11 2023 Lee Gaskin /newsroom/news/list/2023/05/11/saigenci-recruit-recognised-with-prestigious-award /newsroom/news/list/2023/03/28/enzamet-shows-promise-as-prostate-cancer-treatment A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates. March 28 2023 Lee Gaskin /newsroom/news/list/2023/03/28/enzamet-shows-promise-as-prostate-cancer-treatment /newsroom/news/list/2023/03/14/top-talent-to-boost-cancer-research The search for a tailored treatment for cancerous tumours has been bolstered with the appointment of an internationally recognised expert to the South Australian Immunogenomics Cancer Institute (SAiGENCI). March 16 2023 Jessica Stanley /newsroom/news/list/2023/03/14/top-talent-to-boost-cancer-research